» Authors » Athira Anirudhan

Athira Anirudhan

Explore the profile of Athira Anirudhan including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 9
Citations 22
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Atlani M, Kumar A, Ahirwar R, Meenu M, Goel S, Kumari R, et al.
BMC Nephrol . 2024 Apr; 25(1):120. PMID: 38570752
Background: Chronic Kidney Disease of unknown cause (CKDu) a disease of exclusion, and remains unexplained in various parts of the world, including India. Previous studies have reported mixed findings about...
2.
Anirudhan A, Mahema S, Ahmad S, Emran T, Ahmed S, Paramasivam P
Brain Sci . 2023 Nov; 13(11). PMID: 38002511
Mitochondrial dysfunction is well-established in Parkinson's disease (PD); however, its dysfunctions associating with cell organelle connectivity remain unknown. We aimed to establish the crucial cytosolic protein involved in organelle connectivity...
3.
Anirudhan A, Ahmad S, Emran T, Angulo-Bejarano P, Sharma A, Ahmed S
Biomedicines . 2023 Nov; 11(11). PMID: 38001940
Cognitive impairment is anotable complication of type 2 diabetes (T2DM), accompanied by reduced brain-derived neurotrophic factor (BDNF) in the brain and blood. Anti-diabetic drugs reduce hyperglycemia, yet their effect on...
4.
Anirudhan A, Mattethra G, Alzahrani K, Banjer H, Alzahrani F, Halawani I, et al.
Brain Sci . 2023 Jul; 13(7). PMID: 37508933
Pesticides kill neurons, but the mechanism leading to selective dopaminergic loss in Parkinson's disease (PD) is unknown. Understanding the pesticide's effect on dopaminergic neurons (DA) can help to screen and...
5.
Kumari R, Tiwari S, Atlani M, Anirudhan A, Goel S, Kumar A
Biochem Genet . 2023 Jan; 61(4):1548-1566. PMID: 36696070
Global rise in the prevalence of endemic chronic kidney disease of unknown etiology (CKDu) possess major health issues. The prevalence of CKDu is also rising in the Indian population. Besides...
6.
Anirudhan A, Angulo-Bejarano P, Paramasivam P, Manokaran K, Manjunath Kamath S, Murugesan R, et al.
Front Neurosci . 2021 Apr; 15:631892. PMID: 33790735
Parkinson's disease (PD) is a progressive neurodegenerative disease with no definite molecular markers for diagnosis. Metal exposure may alter cellular proteins that contribute to PD. Exploring the cross-talk between metal...
7.
Anirudhan A, Prabu P, Sanyal J, Banerjee T, Guha G, Murugesan R, et al.
NPJ Parkinsons Dis . 2021 Jan; 7(1):3. PMID: 33398051
Metalloproteins utilizes cellular metals which plays a crucial function in brain that linked with neurodegenerative disorders. Parkinson's disease (PD) is a neurodegenerative disorder that affects geriatric population world-wide. Twenty-four metal-binding...
8.
Anirudhan A, Paramasivam P, Murugesan R, Ahmed S
Microb Pathog . 2020 Aug; 147:104415. PMID: 32738283
Bacterial sepsis affects both neonates and adults worldwide. There is no specific anti-sepsis treatment. Disease management mainly depends on early diagnosis. The gold standard blood culturing method is routinely practiced;...
9.
Sanyal J, Anirudhan A, Banerjee T, Guha G, Veerabathiran R, Murugesan R, et al.
Cell Mol Neurobiol . 2019 Sep; 40(3):357-367. PMID: 31512170
Besides clinical and imaging techniques, there is a lack of molecular makers for the diagnosis of Parkinson's disease (PD). There is an immense need to develop biomarkers associated with the...